Instructing Us
We accept instruction via email or post for all types of report. If you intend to instruct us on a regular basis please contact our Sales Team
on info@rapid-medical.co.uk to discuss your firm’s requirements.
MedCo
For MedCo cases simply select Rapid Medical Services in Tier 2
Letters of instruction along with the MedCo number should be sent to info@rapid-medical.co.uk
Standard terms and conditions for MedCo instructions can be found here.
Fast-Track (non-MedCo)
We have access to over 200 experts across multiple disciplines.
Please send letters of instruction to info@rapid-medical.co.uk
Multi Track and Clinical Negligence
Our specialist team will look after your case from instruction to the completion of the final report and you will be assigned a dedicated case handler throughout the life of the case.
Please send letters of instruction to info@rapid-medical.co.uk
Important Information regarding appointments booked on or after 1st July 2022
MedCo has announced that the process for booking Medico-Legal appointments is to change. The changes are as follows:
As users will be aware, the ban on remote examinations was suspended as part of MedCo’s response to Covid-19. In light of the government’s lifting of all remaining restrictions, MedCo has now decided that the suspension will be stopped and the ban reinstated. The suspension will no longer apply to examinations that take place on or after 1 July 2022.
MedCo is aware that for a small group of claimants’ remote examinations may still be required as a result of Covid-19. Therefore, MedCo has decided that in circumstances where the claimant remains vulnerable due to Covid-19, they may, in those limited circumstances, have a remote examination.
Experts are required, if carrying out a remote examination because the claimant is vulnerable due to Covid-19, to record in their report the nature of the claimant’s vulnerability and why that has resulted in the examination being carried out remotely.
This revised guidance (version 7), which now only applies where the claimant has an ongoing Covid-19 related vulnerability, will be kept under review.